1 capsule. VENORUTON contains 300 mg of the mixture in the form of a standardized b -hydroksyetylorutozydów.
Preparation of a protective effect on blood vessels. Rutozydy reduce the permeability of capillaries and increase their resistance, eliminating swelling. They improve blood flow through the vein. Protect against oxidative capillary action of active cellular components of blood. The maximum blood concentration is detected after 2-9 h following administration. In approximately 30% bound to plasma proteins. T 0.5 is 13-25 h. Metabolized in the liver, and excretion by the kidneys.
Chronic venous insufficiency (edema, and pain in the lower limbs, muscle spasms and abnormal sensations), varicose veins of the leg. Vascular skin diseases, ulcers. Hemorrhoids. Supportively mikroangiopatiach in diabetes.
Hypersensitivity to the components of the preparation.
VENORUTON Pregnancy and lactation:
The preparation should not be used in the first trimester of pregnancy.
VENORUTON Undesirable effects:
Rare: disorders of the gastrointestinal tract (bloating, diarrhea, upset stomach), headache, dizziness, fatigue, skin rashes, redness, itching.
Oral. Adults: 300 mg capsule: 1 capsule. 2-3 times daily for 3-4 weeks and then maintained on or in the event of recurrence of symptoms 1 capsule. 2 times per day; in the treatment of hemorrhoids 2-6 caps. per day for 1-4 weeks. The preparation should be swallowed whole during a meal.